Short description
Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.
Description
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.
The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets.
Based in San Mateo, California and Shanghai, Terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in China and globally.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Foster City, California, United States, North America
Founded on
January 1, 2016
Exited on
February 4, 2021
Went public on
February 4, 2021
Stock symbol
TERN
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Absolutely Noaccess, Blurry Noaccess, Absolutely Noaccess, No Way, Noway Youcantaccess, Uh Ohhhh, Blurry Noaccess, No Way, Cannot Access, Noaccess
Sign in for full access
Founders
Weidong Zhong